TGFB1 and cancer: The recent advancements in anti-TGF-β therapies include function-blocking monoclonal antibodies, ligand traps, small molecule inhibitors, and antisense oligonucleotides (AONs), all currently in clinical evaluation for cancer therapy 9, 10.